The clinical trial aims to demonstrate safety and preliminary efficacy of sequential intravenous infusion of the ex vivo expanded mesenchymal stem cells derived from cord tissue and the cord blood stem cells. The study will use, for the first time in clinical research, autologous MSC derived from cryopreserved cord tissue.
http://ift.tt/1w6C6Rk
http://ift.tt/1w6C6Rk
No comments:
Post a Comment